Qure.ai has received a Class III medical device license from Health Canada for all its medical imaging AI products.
The license allows the company to expand its presence into the Canadian healthcare market, according to the vendor. The Class III license covers all of Qure.ai's flagship software, including qXR for chest x-ray images, cER for triaging neurocritical CT images, and qCT for lung nodule management on chest CT images. It also encompasses the company's Qure lung cancer and radiology workflow app, as well as its AI technology for detecting and measuring endotracheal and tracheostomy tube tips, identifying pneumothorax, and triaging critical findings on plain-film chest radiography.
